Love your post,
re “suspect backroom discussions between the FDA and Mesoblast have been ongoing since August 13th. If the mechanism for monitoring quality and potency of MSC’s really is a stumbling block, it needs to be resolved.”
im sure this has come up over the course of rolling submission, pre dated to the 13th, you would assume.
re markers, yes, let’s hope that these are what they seem, that is, a scientific and unbiased indicators.
Cell Therapy News/Articles, page-5973
-
- There are more pages in this discussion • 12,292 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.045(2.98%) |
Mkt cap ! $1.672B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $8.307M | 5.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 151320 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 55652 | 2 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |